Proteomics

Dataset Information

0

Label-free analysis of HCV-associated hepatic fibrosis


ABSTRACT: A differential label-fee proteomics approach was performed using 27 biopsies from patients with HCV-associated hepatic fibrosis. For statistical analysis the patients were grouped into a low and a high fibrosis group. The low fibrosis group contained 13 patients of fibrosis stages 0, 1 and 2, whereas the high fibrosis group contained 14 patients of fibrosis stages 3 and 4 (fibrosis stages according to Batts-Ludwig classification).

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Hepatocyte, Liver

DISEASE(S): Hepatitis C

SUBMITTER: Thilo Bracht  

LAB HEAD: Jun. Prof. Dr. Barbara Sitek

PROVIDER: PXD001474 | Pride | 2015-03-30

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
F191333.dat-pride.pride.mgf.gz Mgf
F191333.dat-pride.pride.mztab.gz Mztab
F191333.dat-pride.xml.gz Xml
F191336.dat-pride.pride.mgf.gz Mgf
F191336.dat-pride.pride.mztab.gz Mztab
Items per page:
1 - 5 of 109
altmetric image

Publications


Hepatic fibrosis and cirrhosis are major health problems worldwide. Until now, highly invasive biopsy remains the diagnostic gold standard despite many disadvantages. To develop noninvasive diagnostic assays for the assessment of liver fibrosis, it is urgently necessary to identify molecules that are robustly expressed in association with the disease. We analyzed biopsied tissue samples from 95 patients with HBV/HCV-associated hepatic fibrosis using three different quantification methods. We per  ...[more]

Similar Datasets

2023-10-31 | PXD038966 | Pride
2023-07-21 | PXD039997 | Pride
2024-06-13 | PXD046061 | Pride
2018-11-15 | PXD007842 | Pride
2017-10-05 | PXD005834 | Pride
2017-06-21 | PXD005777 | Pride
2022-09-06 | PXD025224 | Pride
2024-05-24 | PXD046815 | Pride
2022-04-07 | PXD023943 | Pride
2023-05-10 | PXD038281 | Pride